CVRx (CVRX) Competitors

CVRx (NASDAQ:CVRX) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.

Do institutionals & insiders hold more shares of CVRX or RXST?

75.3% of CVRx shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 13.9% of CVRx shares are held by insiders. Comparatively, 9.4% of RxSight shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community favor CVRX or RXST?

RxSight received 16 more outperform votes than CVRx when rated by MarketBeat users. However, 73.47% of users gave CVRx an outperform vote while only 63.41% of users gave RxSight an outperform vote.

Company	Underperform	Outperform
CVRx	Outperform Votes 36 73.47%	Underperform Votes 13 26.53%
RxSight	Outperform Votes 52 63.41%	Underperform Votes 30 36.59%

Which has more risk & volatility, CVRX or RXST?

CVRx has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. Comparatively, RxSight has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500.

Does the media favor CVRX or RXST?

In the previous week, CVRx had 8 more articles in the media than RxSight. MarketBeat recorded 10 mentions for CVRx and 2 mentions for RxSight. RxSight's average media sentiment score of 1.88 beat CVRx's score of 1.05 indicating that RxSight is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RxSight	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts rate CVRX or RXST?

CVRx currently has a consensus price target of $14.50, indicating a potential upside of 122.39%. RxSight has a consensus price target of $37.90, indicating a potential upside of 141.56%. Given RxSight's higher probable upside, analysts clearly believe RxSight is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
RxSight	2 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.30

Is CVRX or RXST more profitable?

RxSight has a net margin of -23.92% compared to CVRx's net margin of -116.91%. RxSight's return on equity of -14.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-116.91%	-93.06%	-51.78%
RxSight	-23.92%	-14.00%	-12.51%

Which has higher valuation and earnings, CVRX or RXST?

RxSight has higher revenue and earnings than CVRx. RxSight is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$52.87M	3.22	-$59.97M	-$2.18	-2.99
RxSight	$148.31M	4.30	-$48.61M	-$0.67	-23.42

Summary

RxSight beats CVRx on 11 of the 18 factors compared between the two stocks.